Dosage forms and method for ameliorating male erectile dysfunction
US5985889A · kind A · utility
3Cited by
9References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 22, 1998 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Jun 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms so as to maintain a plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.